Van der Boechorststraat 7
Afdeling MMI Kamer B-340
1081 BT Amsterdam
The Netherlands
T +31 20 444 8307
info@microbiome.nl
Nederlands English

About us

Microbiome is leading in the field of innovative molecular microbiological diagnostics. read more >

Diseases

Finding innovative solutions to medical problems drives us. read more >

Management

We firmly believe that investing in our people is investing in our future. Therefore we spend a lot of time and effort on training our team to become highly qualified employees. Our working environment is based on respect for the individual, innovation and creativity. We also value open communication,
a critical attitude and a can-do mentality.
 

Prof. Paul H.M. Savelkoul PhD
General Director

Mr. Savelkoul is professor of Medical Microbiology at the VU University Medical Center. He is head of the section Molecular Diagnostics of the aforementioned department. Additionally, professor Savelkoul is actively involved in several professional committees, for example as chairman of the European Study Group on Molecular Diagnostics and the Dutch Section Microbial Characterization. His research expertise is on molecular diagnostics, detection and typing of pathogenic micro-organisms and molecular epidemiology. Professor Savelkoul is one of the founders of Microbiome.

Prof. Servaas Morré PhD
Scientific Director

Prof. Morré is head Laboratory of Immunogenetics at the department of Pathology of the VU University Medical Center. His research is focused on the immunogenetics of chronic inflammatory diseases and infectious diseases, among which Chlamydia trachomatis, periodontitis and bacterial meningitis. He has 15 years of experience in Chlamydia trachomatis research. In addition, he is scientific director of the European FP6 EpiGenChlamydia Consortium, chairman of the European Society for Chlamydia Research for the 7th ESCR Meeting (2012) in Amsterdam and since 2009 coordinator of some core tasks of the National Institute of Public Health and the Environment (RIVM) concerning Chlamydia trachomatis. He is co-founder and scientific director of Microbiome and uses the knowledge he obtained during the Masterclass BioBusiness (2009-2010) for the development of new products.

Arnold Catsburg
R & D Manager

Mr. Catsburg works at the Department of Medical Microbiology and Infection Prevention of the VU University Medical Center. His internship focused on Real-Time PCR (TaqMan) qualification and quantification of Bifidobacterium, Propionibacterium and Streptococcus in mucosal biopsies from patients with inflammatory bowel disease. After this, he continued his work in the field of molecular microbiology. He developed Real-Time PCR tests for frequent diagnostic use. The targets were M. tuberculosis, T. whipplei, Mycoplasma and Chlamydia trachomatis. In addition, he developed a SNP assay that can be used for genotyping MBL (Mannose Binding Lectin). Besides his activities for Microbiome, which mostly concern research and development, he started writing his thesis about the Chlamydia trachomatis infection.
 


Latest news

As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing

Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate,... read more >

Growing Resistance to Gonorrhea Treatment

Recent research explains why treating gonorrhea has grown more difficult. Scientists from Harvard University, the Centers for Disease Control and Prevention... read more >

Partners of Microbiome

We develop integrated solutions together with leading manufacturers from the diagnostics and pharmaceutical industries, helping them to leverage our leading sample & assay technologies as part of their own offerings. read more >